Collectively, these results further signify the critical role of acetyltransferase p300 in heart attack related cardiac pathologies, and thus acetyltransferase p300 is a potent target of epidrug development for therapy of cardiovascular pathologies (Figure 2). Here, EP300 is linked to myocardial infarction.